Exane Derivatives lifted its position in shares of Constellation Brands Inc (NYSE:STZ) by 1,416.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,889 shares of the company’s stock after purchasing an additional 8,303 shares during the period. Exane Derivatives’ holdings in Constellation Brands were worth $1,773,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Oppenheimer Asset Management Inc. boosted its holdings in shares of Constellation Brands by 50.3% during the second quarter. Oppenheimer Asset Management Inc. now owns 577 shares of the company’s stock worth $112,000 after purchasing an additional 193 shares during the period. Harbour Capital Advisors LLC purchased a new stake in shares of Constellation Brands during the first quarter worth about $117,000. North Star Investment Management Corp. boosted its holdings in shares of Constellation Brands by 11.6% during the second quarter. North Star Investment Management Corp. now owns 748 shares of the company’s stock worth $145,000 after purchasing an additional 78 shares during the period. Hanson McClain Inc. boosted its holdings in shares of Constellation Brands by 0.4% during the second quarter. Hanson McClain Inc. now owns 772 shares of the company’s stock worth $149,000 after purchasing an additional 3 shares during the period. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in shares of Constellation Brands by 609.1% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 780 shares of the company’s stock worth $151,000 after purchasing an additional 670 shares during the period. Institutional investors own 74.90% of the company’s stock.
Shares of Constellation Brands Inc (NYSE STZ) traded down 0.34% during trading on Friday, hitting $211.25. 1,077,599 shares of the company’s stock were exchanged. The stock has a market cap of $41.32 billion, a P/E ratio of 24.27 and a beta of 0.04. The firm has a 50-day moving average price of $204.18 and a 200-day moving average price of $189.92. Constellation Brands Inc has a one year low of $144.00 and a one year high of $214.53.
Constellation Brands (NYSE:STZ) last announced its quarterly earnings results on Thursday, October 5th. The company reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.17 by $0.30. Constellation Brands had a net margin of 21.47% and a return on equity of 22.81%. The firm had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.06 billion. During the same quarter in the prior year, the company earned $1.77 EPS. The company’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts expect that Constellation Brands Inc will post $8.42 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Tuesday, November 7th will be given a $0.52 dividend. The ex-dividend date of this dividend is Monday, November 6th. This represents a $2.08 annualized dividend and a dividend yield of 0.98%. Constellation Brands’s payout ratio is presently 23.85%.
A number of analysts have recently weighed in on STZ shares. Morgan Stanley increased their target price on shares of Constellation Brands from $204.00 to $218.00 and gave the stock an “overweight” rating in a report on Monday, July 3rd. Macquarie started coverage on shares of Constellation Brands in a report on Thursday, September 14th. They set an “outperform” rating and a $227.00 target price for the company. BidaskClub upgraded shares of Constellation Brands from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 12th. Royal Bank Of Canada reiterated a “buy” rating and set a $220.00 target price on shares of Constellation Brands in a report on Wednesday, August 2nd. Finally, Susquehanna Bancshares Inc set a $200.00 target price on shares of Constellation Brands and gave the stock a “hold” rating in a report on Thursday, October 5th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $216.00.
In other news, insider William A. Newlands sold 2,935 shares of the company’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $210.10, for a total value of $616,643.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Barry A. Fromberg sold 2,500 shares of the company’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $208.00, for a total transaction of $520,000.00. The disclosure for this sale can be found here. Insiders sold a total of 122,786 shares of company stock valued at $24,740,206 in the last ninety days. Corporate insiders own 15.59% of the company’s stock.
Constellation Brands Company Profile
Constellation Brands, Inc is an international beverage alcohol company. The Company is a producer and marketer of beer, wine and spirits with operations in the United States, Canada, Mexico, New Zealand and Italy. Its segments include Beer, Wine and Spirits, and Corporate Operations and Other. It is a multi-category supplier (beer, wine and spirits) of beverage alcohol in the United States.
Receive News & Ratings for Constellation Brands Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Brands Inc and related companies with MarketBeat.com's FREE daily email newsletter.